Aorta News and Research

RSS

VentriPoint Diagnostics to present abstract on VMS clinical validation study

VentriPoint Diagnostics Ltd. today announced the abstract of a clinical validation study of the second application of the VentriPoint Medical System (VMS) will be presented at the American College of Cardiology's 59th Annual Scientific Session, March 14 to 16 in Atlanta, Georgia. The study demonstrates the accuracy of the method used by the VentriPoint Medical System (VMS) to generate critical heart measurements in three dimensions from two-dimensional ultrasound images with significantly greater speed and accuracy and at considerably lesser cost than is otherwise possible.

27 Jan 2010

Selective use of DHCA during surgery for CHD in infancy does not impair neurological outcomes

Congenital heart defects (CHD) are the most common birth defects in humans, affecting 8 per 1000 live births with one third of affected children requiring intervention in early infancy. Increasing numbers of survivors combined with developmental expectations for independence, behavioral self-regulation and academic achievement have led to a growing identification of neurobehavioral symptoms in some survivors. A study now suggests that a cooling technique often used in heart operations does not impair neurological outcomes.

27 Jan 2010

Insertion of tiny heart pump without surgery

Cardiologists at the University of Illinois Medical Center at Chicago are leading the Midwest in offering improved treatment options to patients, from the most advanced techniques in angioplasty, to lowering the amount of radiation exposure during heart scans, to opening an innovative clinic that treats heart disease and depression together.

23 Jan 2010

Smoking and high blood pressure increase risk of abdominal aortic aneurysm in men over 60

Men ages 65 and older who have ever smoked should have a one-time, say cardiologists at UT Southwestern Medical Center. Men age 60 and older with a family history of abdominal aortic aneurysm should also consider screening. High blood pressure and a history of smoking can increase your chances of having an abdominal aortic aneurysm.

23 Jan 2010

Gore's next generation Conformable GORE TAG Thoracic Endoprosthesis enters clinical trial

W. L. Gore & Associates (Gore) announced the first human implants of the next generation Conformable GORE TAG® Thoracic Endoprosthesis in the United States for the treatment of traumatic transection of the thoracic aorta.

8 Jan 2010

Embrella Cardiovascular completes first clinical case using Embrella Embolic Deflector

Embrella Cardiovascular, Inc., a privately held company announced that it has completed its first clinical case using the Embrella Embolic Deflector™. The company has developed a novel technology designed to make less invasive cardiovascular procedures safer for patients by decreasing the risk of emboli traveling to the brain.

6 Jan 2010

UT Southwestern doctor uses a viable alternative in aortic graft surgery

A vascular surgical technique pioneered at UT Southwestern Medical Center and designed to replace infected aortic grafts with the body's own veins has proved more durable and less prone to new infection than similar procedures using synthetic and cadaver grafts.

31 Dec 2009

Researchers use hydrogels to induce significant vasculature growth in areas of damaged tissue

Regenerative medicine therapies often require the growth of functional, stable blood vessels at the site of an injury. Using synthetic polymers called hydrogels, researchers at the Georgia Institute of Technology have been able to induce significant vasculature growth in areas of damaged tissue.

22 Dec 2009

Geisinger installs catheter-based cardiac assist device, Impella 2.5

A minimally invasive, catheter-based cardiac assist device - the Impella 2.5 - is credited with saving the life of 86-year-old Rose Lombardo of Hazleton. Grandmother to seven and great-grandmother to another 12, Rose was "at death's door" after suffering concurrent heart attacks, according to her daughter, Gabriella Norgard.

8 Dec 2009

Discovery presents a vital step towards efficient treatment of vascular injuries

Hyperglycemia starts a complex chain of events that damages blood vessels and cause cardiovascular disease. Scientists at Lund University Diabetes Centre (LUDC) have now been able to demonstrate why this happens, as well as how the destructive chain can be broken.

7 Dec 2009

NHLBI-supported research shares new strategies on hypertension, heart defect and air pollution

New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18.

20 Nov 2009

W. L. Gore to distribute QXMédical's Q50 Stent Graft Balloon Catheter

W. L. Gore & Associates today announced it has entered into a partnership with QXMédical, LLC, a medical device development and marketing company. As part of the agreement, Gore will distribute the Q50 Stent Graft Balloon Catheter which is designed for use with aortic stent grafts that treat abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA).

18 Nov 2009

New generation of implanted devices help a failing heart function properly

A new generation of implanted devices that help a failing heart function properly is significantly more effective than the previous version, making these new devices an appropriate permanent therapy for many of the more than 5 million Americans who suffer from heart failure.

18 Nov 2009

New shunt procedure may save infants with underdeveloped heart

Infants born with a severely underdeveloped heart are more likely to survive to their first birthday when treated with a new shunt procedure - yet it may not be the safest surgery long term, according to research presented at the American Heart Association's Scientific Sessions 2009.

16 Nov 2009

Decreased heart functions associated with fat collection in different body locations: Study

Researchers from Boston University School of Medicine (BUSM) have shown that fat collection in different body locations, such as around the heart and the aorta and within the liver, are associated with certain decreased heart functions. The study, which appears on-line in Obesity, also found that measuring a person's body mass index (BMI) does not reliably predict the amount of undesired fat in and around these vital organs.

13 Nov 2009

GORE TAG Thoracic Endoprosthesis receives European CE Mark approval

W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG® Thoracic Endoprosthesis. The device is available in an expanded portfolio of sizes to meet a broad range of patient needs and was engineered to treat multiple etiologies including thoracic aortic aneurysms (TAAs), traumatic aortic transections and thoracic aortic dissections.

11 Nov 2009

Cook Medical and AOPA partner to offer AAA screenings at AOPA Aviation Summit

Cook Medical is partnering with the Aircraft Owners and Pilots Association (AOPA) at this year’s AOPA Aviation Summit in Tampa, Fla. from November 5-7 to provide free abdominal aortic aneurysm (AAA) screenings to its attendees at high risk for AAA.

5 Nov 2009

New FDA-approved heart pump for high-risk patients

Cardiologists at the University of Illinois Medical Center are using a new heart pump that can be inserted without the need for surgery and allows them to treat high-risk patients with a procedure to unblock their heart arteries.

4 Nov 2009

Bolton Medical reports first U.S. trial of its Relay Plus System for endovascular stent-graft procedures

Bolton Medical announced today the first use of its new Relay Plus System in the U.S. Relay Clinical Trial. The case took place at the University of Pennsylvania Medical Center in Philadelphia, PA.

29 Oct 2009

First human implants of the Conformable GORE TAG Thoracic Endoprosthesis performed

W. L. Gore & Associates (Gore) today announced the first human implants of the next generation Conformable GORE TAG® Thoracic Endoprosthesis for the treatment of thoracic aortic aneurysms (TAAs). The first implants were performed by Joshua Rovin, MD and Eugene Murphy, MD, at Bayfront Medical Center and William McMillan, MD and Scott Schultz, MD, at North Memorial Medical Center.

21 Oct 2009